Erschienen in:
01.04.2015 | Case study
“Full bioresorbable jacket”
A new era has begun
verfasst von:
Dr. O. Dörr, C. Liebetrau, F. Hecker, J. Wiebe, H. Möllmann, C. Hamm, H. Nef
Erschienen in:
Herz
|
Ausgabe 2/2015
Einloggen, um Zugang zu erhalten
Excerpt
Chronic total occlusion (CTO) remains a challenging lesion subset for percutaneous coronary intervention (PCI). Multiple overlapping stents are often required for interventional treatment of CTO (CTO-PCI), the so-called full metal jacket (FMJ) approach [
1,
2]. However, the length of the stented segment is an independent predictor of in-stent restenosis. Completely absorbable scaffolds have potential advantages over current metallic coronary stents and might be an alternative to metallic drug-eluting stents (DES) [
3,
4]. Bioresorbable coronary scaffolds seem to provide short-term vessel scaffolding with drug delivery capability while avoiding the long-term limitations of metallic stents, such as late stent thrombosis and stent stenosis. …